These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 17006433

  • 41. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA, Johnson JC.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):201-12. PubMed ID: 15044052
    [Abstract] [Full Text] [Related]

  • 42. Dopaminergic Drug Effects on Probability Weighting during Risky Decision Making.
    Ojala KE, Janssen LK, Hashemi MM, Timmer MHM, Geurts DEM, Ter Huurne NP, Cools R, Sescousse G.
    eNeuro; 2018 Mar 19; 5(2):. PubMed ID: 29632870
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol.
    Bossong MG, van Hell HH, Jager G, Kahn RS, Ramsey NF, Jansma JM.
    Eur Neuropsychopharmacol; 2013 Dec 19; 23(12):1687-97. PubMed ID: 23928295
    [Abstract] [Full Text] [Related]

  • 47. Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents.
    Vlachou S, Nomikos GG, Stephens DN, Panagis G.
    Behav Pharmacol; 2007 Jul 19; 18(4):311-9. PubMed ID: 17551324
    [Abstract] [Full Text] [Related]

  • 48. Ventromedial prefrontal cortex damage alters relative risk tolerance for prospective gains and losses.
    Pujara MS, Wolf RC, Baskaya MK, Koenigs M.
    Neuropsychologia; 2015 Dec 19; 79(Pt A):70-5. PubMed ID: 26597003
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU, Liu Q, Makriyannis A.
    Psychopharmacology (Berl); 2006 Jan 19; 184(1):36-45. PubMed ID: 16307294
    [Abstract] [Full Text] [Related]

  • 51. Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial.
    Ahmed AI, van den Elsen GA, Colbers A, van der Marck MA, Burger DM, Feuth TB, Rikkert MG, Kramers C.
    Eur Neuropsychopharmacol; 2014 Sep 19; 24(9):1475-82. PubMed ID: 25035121
    [Abstract] [Full Text] [Related]

  • 52. Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat.
    Silva L, Harte-Hargrove L, Izenwasser S, Frank A, Wade D, Dow-Edwards D.
    Neurosci Lett; 2015 Aug 18; 602():89-94. PubMed ID: 26118897
    [Abstract] [Full Text] [Related]

  • 53. Self-administration of edible Δ9-tetrahydrocannabinol and associated behavioral effects in mice.
    Smoker MP, Mackie K, Lapish CC, Boehm SL.
    Drug Alcohol Depend; 2019 Jun 01; 199():106-115. PubMed ID: 31029878
    [Abstract] [Full Text] [Related]

  • 54. Benefits of rivastigmine on attention in dementia associated with Parkinson disease.
    Wesnes KA, McKeith I, Edgar C, Emre M, Lane R.
    Neurology; 2005 Nov 22; 65(10):1654-6. PubMed ID: 16301500
    [Abstract] [Full Text] [Related]

  • 55. Adolescent risky decision-making: neurocognitive development of reward and control regions.
    Van Leijenhorst L, Gunther Moor B, Op de Macks ZA, Rombouts SA, Westenberg PM, Crone EA.
    Neuroimage; 2010 May 15; 51(1):345-55. PubMed ID: 20188198
    [Abstract] [Full Text] [Related]

  • 56. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K, Mishima K, Hazekawa M, Sano K, Irie K, Orito K, Egawa T, Kitamura Y, Uchida N, Nishimura R, Egashira N, Iwasaki K, Fujiwara M.
    Brain Res; 2008 Jan 10; 1188():157-64. PubMed ID: 18021759
    [Abstract] [Full Text] [Related]

  • 57. Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats.
    Freels TG, Baxter-Potter LN, Lugo JM, Glodosky NC, Wright HR, Baglot SL, Petrie GN, Yu Z, Clowers BH, Cuttler C, Fuchs RA, Hill MN, McLaughlin RJ.
    J Neurosci; 2020 Feb 26; 40(9):1897-1908. PubMed ID: 31953372
    [Abstract] [Full Text] [Related]

  • 58. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.
    Hart CL, Haney M, Vosburg SK, Comer SD, Foltin RW.
    Psychopharmacology (Berl); 2005 Sep 26; 181(2):237-43. PubMed ID: 15830233
    [Abstract] [Full Text] [Related]

  • 59. Effects of tetrahydrocannabinol on glucose uptake in the rat brain.
    Miederer I, Uebbing K, Röhrich J, Maus S, Bausbacher N, Krauter K, Weyer-Elberich V, Lutz B, Schreckenberger M, Urban R.
    Neuropharmacology; 2017 May 01; 117():273-281. PubMed ID: 28219717
    [Abstract] [Full Text] [Related]

  • 60. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L, Mata M, Alcacer J, Oliver M, Sancho-Tello M, Martín de Llano JJ, Camps C, Galbis J, Carretero J, Carda C.
    PLoS One; 2020 May 01; 15(2):e0228909. PubMed ID: 32049991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.